Breakfast with Master 1 
Beyond the Clinical Trial Data : Impact of Real-World Experience of ZEPOSIA®
|
Room B |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Hyun Soo Kim (Chonnam National University, Korea) |
| Speaker(s) |
07:30-08:00 |
Refining Evidence-Based Strategies in UC Practice: Positioning
Dong Hyun Kim (Chonnam National University, Korea) |
Breakfast with Master 2 
Sequential treatment in Ulcerative Colitis
|
Room C |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Sang Wook Kim (Chonbuk National University, Korea) |
| Speaker(s) |
07:30-08:00 |
The Current Role of Filgotinib in Ulcerative Colitis
Fumihito Hirai (Fukuoka University, Japan) |
Breakfast with Master 3 
Start Strong in Ulcerative Colitis with Upadacitinib
|
Room D |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Geom-Seog Seo (Wonkwang University, Korea) |
| Speaker(s) |
07:30-07:45 |
When Time Matters in Ulcerative Colitis: Upadacitinib for Urgent Disease Control
Baek Dong Hoon (Pusan National University, Korea) |
| 07:45-08:00 |
Connecting the Dots: Evidence to Insight with Upadacitinib
Sang-Bum Kang (The Catholic University of Korea, Korea) |
Breakfast with Master 4 
Transforming Bowel Preparation Strategies in IBD: A Change in Perspective Toward Mini Oral Sulfate Tablets
|
Room E |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Jae Myung Cha (Kyung Hee University, Korea) |
| Speaker(s) |
07:30-08:00 |
Efficacy and Safety of Bowel Preparations in Patients with IBD
Jaeseung Soh (Hallym University, Korea) |
Breakfast with Master 5 
New and Now: Introducing Etrasimod in Ulcerative Colitis
|
Room F |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Jae Hee Cheon (Yonsei University, Korea) |
| Speaker(s) |
07:30-08:00 |
Etrasimod in Ulcerative Colitis: Clinical Evidence and Its Role in Therapy
David T. Rubin (University of Chicago, USA) |
|
Clinical Symposium 2 (ADT)
Advanced IBD Therapies: Beyond Competition, Toward Optimization
|
Room A |
| Date & Time
|
June 26 (Fri), 08:30-10:00 |
| Chair(s) |
Edward V. Loftus Jr. (Mayo Clinic College of Medicine and Science, USA)
Dong Soo Han (Hanyang University, Korea) |
| Speaker(s) |
08:30-08:50 |
Anti-TNF Therapy: Still Standing Strong and Getting Smarter
Byong Duk Ye (University of Ulsan, Korea) |
| 08:50-09:10 |
Anti-Integrin Therapy: Ensuring Safety, Enhancing Efficacy
Vipul Jairath (Western University, Canada) |
| 09:10-09:30 |
IL-23 Inhibitors: Navigating the Expanding Choices in IBD Care
Silvio Danese (University Vita-Salute San Raffaele, Italy) |
| 09:30-09:50 |
JAK Inhibitors and S1P Receptor Modulators: Emerging Contenders Beyond Biologics
Taku Kobayashi (Kitasato University, Japan) |
| 09:50-10:00 |
Discussion
|
|
Clinical Symposium 3 (Big Data)
Transforming IBD Research Through Big Data and Large Cohort Studies
|
Room B |
| Date & Time
|
June 26 (Fri), 08:30-10:00 |
| Chair(s) |
Gilaad G. Kaplan (University of Calgary, Canada)
Hyun-Soo Kim (Yonsei University, Korea) |
| Speaker(s) |
08:30-08:50 |
Seeing Patterns, Shaping Care: The Evolution of Big Data in IBD Research
Gilaad G. Kaplan (University of Calgary, Canada) |
| 08:50-09:10 |
Real-World Data in Action: Unlocking Insights from the Korean National Claims Data
Hyuk Yoon (Seoul National University, Korea) |
| 09:10-09:30 |
Nationwide Big Data Insights into the Epidemiology and Trends of IBD in Taiwan
Shu-Chen Wei (National Taiwan University, Taiwan) |
| 09:30-09:50 |
Toward Prevention: Expanding Perspectives on Early-Life and Environmental Risk Factors
Sun-Ho Lee (University of Toronto, Canada) |
| 09:50-10:00 |
Discussion
|
|
Translational Symposium (Microbiome/Omics)
Microbiome & Omics in IBD: Translating Science into Care
|
Room C |
| Date & Time
|
June 26 (Fri), 08:30-10:00 |
| Chair(s) |
Jae Hee Cheon (Yonsei University, Korea)
Takanori Kanai (Keio University, Japan) |
| Speaker(s) |
08:30-08:50 |
Microbial Signatures in IBD: Toward Precision Diagnosis and Subtype Stratification Through Multi-Omics
Chang Kyun Lee (Kyung Hee University, Korea) |
| 08:50-09:10 |
Shaping the Gut Microbiome: Therapeutic Interventions and Clinical Implications for IBD
Hong Koh (Yonsei University, Korea) |
| 09:10-09:30 |
Microbiota-Mediated Fibrosis: Unraveling Complications in Crohn’s Disease
Ren Mao (Sun Yat-sen University, China) |
| 09:30-09:50 |
Microbes as Targets, Mediators, and Predictors of Therapy Response in IBD
Eytan Wine (The Hospital for Sick Children, Canada) |
| 09:50-10:00 |
Discussion
|
|
Clinical Symposium 4 (Colorectal Neoplasm)
Toward Precision Colorectal Cancer Screening: Integrating Risk, Tools, and Innovation
|
Room D |
| Date & Time
|
June 26 (Fri), 08:30-10:00 |
| Chair(s) |
Seung-Jae Myung (University of Ulsan, Korea)
Francis K.L. Chan (The Chinese University of Hong Kong, Hong Kong) |
| Speaker(s) |
08:30-08:50 |
FIT or Colonoscopy: What Is the Best Strategy for CRC Screening?
Wen-Feng Hsu (National Taiwan University, Taiwan) |
| 08:50-09:10 |
Personalized Screening Strategies: Beyond Age-Based CRC Guidelines
Jae Myung Cha (Kyung Hee University, Korea) |
| 09:10-09:30 |
Revolutionizing Biomarkers in Colorectal Cancer Screening
Francis K.L. Chan (The Chinese University of Hong Kong, Hong Kong) |
| 09:30-09:50 |
Risk-Adapted Surveillance after Polypectomy & ESD: Who, When, and How
Su Young Kim (Yonsei University, Korea) |
| 09:50-10:00 |
Discussion
|
|
AOCC Plenary Session
|
Room A |
| Date & Time
|
June 26 (Fri), 11:20-12:10 |
| Chair(s) |
Dong Il Park (Sungkyunkwan University, Korea)
Sung-Ae Jung (Ewha Womans University, Korea) |
| Speaker(s) |
11:20-11:32 |
Mesenteric Inflammation-Associated Fibroblasts Drive Intestinal Barrier Dysfunction and Promote Crohn’s Disease Progression
Jihye Park (Ewha Womans University, Korea) |
| 11:32-11:44 |
Integrated Metabolomic and Genetic Analyses Reveal Loss of Protective Docosahexaenoic Acid as a Key Driver Linking Ultra-Processed Food to Crohn’s Disease Risk
Jie Chen (The Third Xiangya Hospital of Central South University, China) |
| 11:44-11:56 |
Childhood Exposure to a Sibling with Crohn’s Disease Alters Gut Microbiome and Increases Crohn’s Disease Susceptibility
Rirong Chen (University of Toronto, Canada) |
| 11:56-12:08 |
Efficacy and Safety of Obefazimod in Moderately to Severely Active Ulcerative Colitis: Pooled Phase 3 Results From ABTECT Trials, Including a Japan and Korea Subgroup Analysis
Tadakazu Hisamatsu (Kyorin University, Japan) |
| 12:08-12:10 |
Closing
|
Luncheon Symposium 2 
Beyond Similarity: Clinical and Real-World Insights into Ustekinumab Biosimilars
|
Room B |
| Date & Time
|
June 26 (Fri), 12:20-13:00 |
| Chair(s) |
Katsuyoshi Matsuoka (Toho University, Japan)
Jonghun Lee (Dong-A University, Korea) |
| Speaker(s) |
12:20-12:40 |
What is Same and Different? : Clinical Value of Ustekinumab Biosimilar
Eun Soo Kim (Kyungpook National University, Korea) |
| 12:40-13:00 |
From Evidence to Experience : Real-World Application of Ustekinumab Biosimilar
Sang Hyoung Park (University of Ulsan, Korea) |
Luncheon Symposium 3 
Evolving IBD Care in the Era of IL-23 Inhibitor
|
Room C |
| Date & Time
|
June 26 (Fri), 12:20-13:00 |
| Chair(s) |
Masayuki Saruta (Jikei University, Japan)
Young-Ho Kim (Sungkyunkwan University, Korea) |
| Speaker(s) |
12:20-12:35 |
Unmet Needs in Korean IBD Care: Evolving Expectations for New Therapeutic Options
Seong-Joon Koh (Seoul National University, Korea) |
| 12:35-13:00 |
Advancing IBD Care with Guselkumab: Insights from Clinical and Real World Evidence
David T. Rubin (University of Chicago, USA) |
|
Luncheon Symposium 4
Fast-Acting, Long-Lasting Control: Upadacitinib in IBD
|
Room B |
| Date & Time
|
June 26 (Fri), 13:00-13:40 |
| Chair(s) |
Zhihua Ran (Shanghai University, China)
Sung-Ae Jung (Ewha Womans University, Korea) |
| Speaker(s) |
13:00-13:20 |
Optimizing Treatment Strategies in Ulcerative Colitis with Upadacitinib
Byong Duk Ye (University of Ulsan, Korea) |
| 13:20-13:40 |
Shaping a New Paradigm in Crohn’s Disease Management: The Role of Upadacitinib
Edward V. Loftus Jr. (Mayo Clinic College of Medicine and Science, USA) |
Luncheon Symposium 5 
A New Era in IBD Treatment: Optimizing Infliximab Therapy
|
Room C |
| Date & Time
|
June 26 (Fri), 13:00-13:40 |
| Chair(s) |
Zhanju Liu (Tongji University, China)
Yoon Tae Jeen (Korea University, Korea) |
| Speaker(s) |
13:00-13:20 |
Real-World Experience with Subcutaneous Infliximab: Updated Global Evidence
Silvio Danese (University Vita-Salute San Raffaele, Italy) |
| 13:20-13:40 |
Personalizing IBD Treatment: The Role of Therapeutic Drug Monitoring in Infliximab Therapy
Sung Noh Hong (Sungkyunkwan University, Korea) |
|
Clinical Symposium 5 (Pregnancy & Obesity)
Global IBD Perspectives: Pregnancy and Obesity across East and West
|
Room A |
| Date & Time
|
June 26 (Fri), 16:20-17:50 |
| Chair(s) |
You Sun Kim (Hallym University, Korea)
Joana Torres (University of Lisbon, Portugal) |
| Speaker(s) |
16:20-16:40 |
Pregnancy in IBD: Essential Knowledge for Clinicians and Patients
Joana Torres (University of Lisbon, Portugal) |
| 16:40-17:00 |
IBD and Pregnancy in East Asia: Regional Insights and Clinical Experience
Eun Mi Song (Ewha Womans University, Korea) |
| 17:00-17:20 |
Epidemiology and Pathophysiology of Obesity and IBD: Asian Perspectives
Jaeyoung Chun (Yonsei University, Korea) |
| 17:20-17:40 |
Optimizing Medical Therapy in IBD Patients with Obesity
Siddharth Singh (Mayo Clinic Arizona, USA) |
| 17:40-17:50 |
Discussion
|
|
Clinical Symposium 6 (Small Bowel & Nutrition)
Current Perspective on Diet and Nutrition in IBD
|
Room B |
| Date & Time
|
June 26 (Fri), 16:20-17:50 |
| Chair(s) |
Dong Kyung Chang (Sungkyunkwan University, Korea)
Tadakazu Hisamatzu (Kyorin University, Japan) |
| Speaker(s) |
16:20-16:40 |
Dietary and Environmental Risk Factors in IBD: Theory and Practice
Rupa Banerjee (AIG Hospitals, India) |
| 16:40-17:00 |
Impact of Diet and Urban Environment in Crohn’s Disease: Diet-omics Cohort Study
Rui Feng (Sun Yat-Sen University, China) |
| 17:00-17:20 |
Tools and Challenges of Dietary Assessment in IBD and Colorectal Diseases: Lessons From Clinical Experiences
Yun Jeong Lim (Dongguk university, Korea) |
| 17:20-17:40 |
Recent Advances in Enteral Nutrition for IBD: Beyond THE WALLS
Robert V Bryant (The Queen Elizabeth Hospital, Australia) |
| 17:40-17:50 |
Discussion
|
|
KASID-GEST Joint Symposium
Current Status and Future Perspectives in Intestinal Diseases
|
Room C |
| Date & Time
|
June 26 (Fri), 16:20-17:50 |
| Chair(s) |
Shu-Chen Wei (National Taiwan University, Taiwan)
Jeong-Sik Byeon (University of Ulsan, Korea) |
| Speaker(s) |
16:20-16:40 |
Current Status and Treatment Trends of IBD in Taiwan
Tzung-Jiun Tsai (Kaohsiung Veterans General Hospital, Taiwan) |
| 16:40-17:00 |
Current Status and Treatment Trends of IBD in Korea
Joo Hye Song (Konkuk University, Korea) |
| 17:00-17:20 |
Current Status and Treatment Trends of Colorectal Cancer in Taiwan
Li-Chun Chang (National Taiwan University, Taiwan) |
| 17:20-17:40 |
Current Status and Treatment Trends of Colorectal Neoplasms in Korea
Seong-Jung Kim (Chosun University, Korea) |
| 17:40-17:50 |
Discussion
|
|
Clinical Symposium 7 (AOCC for Pediatricians)
Bridging Evidence and Practice in Pediatric IBD
|
Room D |
| Date & Time
|
June 26 (Fri), 16:20-17:50 |
| Chair(s) |
Eytan Wine (The Hospital for Sick Children, Canada)
Kyung Mo Kim (University of Ulsan, Korea) |
| Speaker(s) |
16:20-16:40 |
Early-Onset Pediatric IBD: From Immune Pathways to Clinical Application
Takashi Ishige (Gunma University, Japan) |
| 16:40-17:00 |
Pediatric Ulcerative Colitis: Key Updates from the Latest ECCO–ESPGHAN Guidelines
Eytan Wine (The Hospital for Sick Children, Canada) |
| 17:00-17:20 |
Real-World Practice of Nutritional Therapy in Pediatric Crohn’s Disease
Hyeji Lim (Yonsei University, Korea) |
| 17:20-17:40 |
Practical Precision Medicine in Pediatric IBD: Advanced Therapies in Real-World Settings
Mi Jin Kim (Sungkyunkwan University, Korea) |
| 17:40-17:50 |
Discussion
|
|
IMKASID for Young Researchers
|
Room G |
| Date & Time
|
June 26 (Fri), 14:30-16:00 |
| Chair(s) |
Young Sun Kim (Seoul National University, Korea)
Jeong-Sik Byeon (University of Ulsan, Korea) |
| Speaker(s) |
14:30-14:45 |
Optimizing IBD Outcomes Across the Lifespan: Differential Positioning of Biologics and Small Molecules from Pediatrics to Adulthood
Junghyun Noh (Seoul National University, Korea) |
| 14:45-15:00 |
Clinical Characteristics and Surgical Outcomes of Adolescent-Onset Crohn’s Disease Compared with Pediatric- and Adult-Onset Disease: A Multicenter Study
Soojin Kang (Ewha Womans University, Korea)
Minjee Kim (Sungkyunkwan University, Korea) |
| 15:00-15:15 |
Tailoring Colorectal Cancer Screening for Older Adults: Strategies Beyond Routine Colonoscopy
Geunhyuk Choi (Soonchunhyang University, Korea) |
| 15:15-15:30 |
The Future of CRC Screening : Moving Beyond FIT
Yeojin Lee (University of Ulsan, Korea) |
| 15:30-15:45 |
Artificial Intelligence in Capsule Endoscopy: Current Landscape and Future Perspectives
Kwangmin Joo (Dong-A University, Korea) |
| 15:45-16:00 |
Gut Microbiome Alterations in IBD Patients with Obesity
Hee Won Kwon (Kyungpook National University, Korea) |
|
Meet the Expert 1
Advancing IBD Care with Subcutaneous Infliximab
|
Exhibition |
| Date & Time
|
June 26 (Fri), 15:50-16:20 |
| Speaker(s) |
15:50-16:20 |
Redefining IBD Treatment Strategies: The Role of Subcutaneous Infliximab
Rupert Leong (University of Sydney, Australia) |
|
Meet the Expert 2
Emerging Treatment in Crohn’s Disease with Fistula
|
Exhibition |
| Date & Time
|
June 26 (Fri), 15:50-16:20 |
| Speaker(s) |
15:50-16:20 |
Clinical Efficacy and Real world experience with Guselkumab in CD with Fistula
Vipul Jairath (Western University, Canada) |
